Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 30,206 shares at $42.10 ($1.3M) on 2025-03-03, disclosed to the SEC on 2025-03-04.
Seasonal sale ($1.3M) by EVP & Chief Commercial Officer — this insider has traded RARE in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.10 | 15,103 | $636K | 50.0% |
| 2 | $42.10 | 15,103 | $636K | 50.0% |
| Total | $42.10 avg | 30,206 | $1.3M | 100% |
| Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |
| RARE | SELL | 2023-03-03 | $166K | — | Filing → |